Stay updated on Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedUpdated to v3.0.2 (Sept 2025) with new 2025 dates and an estimated last-update label. Added ACT17131 plain-language results link from Sanofi/Principia Biopharma, while older entries, revision v3.0.1, and 'Back to Top' were removed.SummaryDifference1%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and specific drug safety information, while removing previous location details and references to certain diseases.SummaryDifference2%
- Check25 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
Stay in the know with updates to Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.